Latest News & Features
Africa
The World Trade Organization has amended its intellectual property rules to make it easier for poor countries to access affordable medicines. 24 January 2017
Big Pharma
Gilead’s marketing authorisation application for sofosbuvir 400mg, velpatasvir 100mg and voxilaprevir 100mg—treatments for chronic hepatitis C virus—is under assessment by the European Medicines Agency. 23 January 2017
Americas
Merck has agreed a settlement and licensing agreement with Bristol-Myers Squibb (BMS) and Ono Pharmaceutical under which it will pay the companies $625 million. 23 January 2017
Americas
Novartis, Mitsubishi Tanabe Pharma and Mitsui Sugar have filed a complaint against Aurobindo Pharma for patent infringement. 20 January 2017
Americas
The US Supreme Court has declined to hear the Johnson & Johnson v Rembrandt Vision Technologies patent case centring on contact lens technology. 20 January 2017
Americas
Biogen and Forward Pharma, a Denmark-based company, have entered into a settlement and licensing agreement under which Biogen will pay Forward Pharma $1.25 billion. 19 January 2017
Americas
Mallinckrodt ARD, formerly known as Questcor Pharmaceuticals, and its parent company, Mallinckrodt, will pay $100 million in a settlement over antitrust charges made by the Federal Trade Commission. 19 January 2017
Americas
The Federal Trade Commission and the Department of Justice have issued an update to the Antitrust Guidelines for Licensing of Intellectual Property, modernising the 1995 guidelines. 18 January 2017
Americas
Teva has sued Mylan for alleged patent infringement over Copaxone, a treatment for patients with relapsing-remitting forms of multiple sclerosis. 18 January 2017
Biotechnology
UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR. 17 January 2017